体外循环中一氧化氮对先天性心脏病手术幼儿无呼吸机天数的影响:NITRIC随机临床试验
这项双盲、多中心随机临床试验在澳大利亚、新西兰和荷兰的6个儿童心脏手术中心纳入1371例2岁以下先天性心脏病手术患儿,比较体外循环氧合器内给予20 ppm一氧化氮与标准体外循环对无呼吸机天数的影响。结果显示两组无呼吸机天数中位数分别为26.6天与26.4天,绝对差异为-0.01天(95%CI,-0.25至0.22;P=0.92),无显著差异;低心输出量综合征、体外生命支持或死亡的复合终点调整比值比为1.12(95%CI,0.85至1.47)。作者结论认为这些发现不支持在心脏手术期间经体外循环氧合器给予一氧化氮。
要点
- 在2岁以下先天性心脏病体外循环手术患儿中,体外循环氧合器内给予20 ppm一氧化氮与标准体外循环相比,无呼吸机天数无显著差异。
- 一氧化氮组与标准治疗组无呼吸机天数中位数分别为26.6天与26.4天,绝对差异为-0.01天(95%CI,-0.25至0.22;P=0.92)。
- 低心输出量综合征、体外生命支持或死亡的复合终点调整比值比为1.12(95%CI,0.85至1.47)。
核心结论
- 在2岁以下接受先天性心脏病体外循环手术的儿童中,经体外循环给予一氧化氮未显著影响无呼吸机天数。
- 这些发现不支持在心脏手术期间经体外循环氧合器给予一氧化氮。
研究设计与样本
- 双盲、多中心、随机临床试验,在澳大利亚、新西兰和荷兰的6个儿童心脏手术中心开展。
- 2017年7月至2021年4月随机分配1371例2岁以下接受先天性心脏病手术的儿童,最后一名参与者28天随访于2021年5月24日完成。
- 患儿被分配至体外循环氧合器内给予20 ppm一氧化氮组(n=679)或未给一氧化氮的标准体外循环组(n=685)。
- 主要终点为从体外循环开始至第28天的无呼吸机天数。
主要发现
- 1371例随机患者(平均[SD]年龄21.2[23.5]周;587例女孩[42.8%])中,1364例(99.5%)完成试验。
- 一氧化氮组与标准治疗组无呼吸机天数中位数分别为26.6天(IQR,24.4至27.4)与26.4天(IQR,24.0至27.2),绝对差异为-0.01天(95%CI,-0.25至0.22;P=0.92)。
- 一氧化氮组22.5%与标准治疗组20.9%的患儿在48小时内发生低心输出量综合征、48小时内需要体外支持或至第28天死亡,调整比值比为1.12(95%CI,0.85至1.47)。
- 其他次要结局在两组间无显著差异。
临床怎么用
- 作者结论认为这些发现不支持在心脏手术期间经体外循环氧合器给予一氧化氮。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In children undergoing heart surgery, nitric oxide administered into the gas flow of the cardiopulmonary bypass oxygenator may reduce postoperative low cardiac output syndrome, leading to improved recovery and shorter duration of respiratory support. It remains uncertain whether nitric oxide administered into the cardiopulmonary bypass oxygenator improves ventilator-free days (days alive and free from mechanical ventilation). OBJECTIVE: To determine the effect of nitric oxide applied into the cardiopulmonary bypass oxygenator vs standard care on ventilator-free days in children undergoing surgery for congenital heart disease. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, multicenter, randomized clinical trial in 6 pediatric cardiac surgical centers in Australia, New Zealand, and the Netherlands. A total of 1371 children younger than 2 years undergoing congenital heart surgery were randomized between July 2017 and April 2021, with 28-day follow-up of the last participant completed on May 24, 2021. INTERVENTIONS: Patients were assigned to receive nitric oxide at 20 ppm delivered into the cardiopulmonary bypass oxygenator (n = 679) or standard care cardiopulmonary bypass without nitric oxide (n = 685). MAIN OUTCOMES AND MEASURES: The primary end point was the number of ventilator-free days from commencement of bypass until day 28. There were 4 secondary end points including a composite of low cardiac output syndrome, extracorporeal life support, or death; length of stay in the intensive care unit; length of stay in the hospital; and postoperative troponin levels. RESULTS: Among 1371 patients who were randomized (mean [SD] age, 21.2 [23.5] weeks; 587 girls [42.8%]), 1364 (99.5%) completed the trial. The number of ventilator-free days did not differ significantly between the nitric oxide and standard care groups, with a median of 26.6 days (IQR, 24.4 to 27.4) vs 26.4 days (IQR, 24.0 to 27.2), respectively, for an absolute difference of -0.01 days (95% CI, -0.25 to 0.22; P = .92). A total of 22.5% of the nitric oxide group and 20.9% of the standard care group developed low cardiac output syndrome within 48 hours, needed extracorporeal support within 48 hours, or died by day 28, for an adjusted odds ratio of 1.12 (95% CI, 0.85 to 1.47). Other secondary outcomes were not significantly different between the groups. CONCLUSIONS AND RELEVANCE: In children younger than 2 years undergoing cardiopulmonary bypass surgery for congenital heart disease, the use of nitric oxide via cardiopulmonary bypass did not significantly affect the number of ventilator-free days. These findings do not support the use of nitric oxide delivered into the cardiopulmonary bypass oxygenator during heart surgery. TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12617000821392.
引用
- Schlapbach LJ, Gibbons KS, Horton SB, et al. Effect of Nitric Oxide via Cardiopulmonary Bypass on Ventilator-Free Days in Young Children Undergoing Congenital Heart Disease Surgery: The NITRIC Randomized Clinical Trial. JAMA. 2022. PMID: 35759691. doi:10.1001/jama.2022.9376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。